[HTML][HTML] The role of selected non-coding RNAs in the biology of non-small cell lung cancer
K Kiełbowski, K Ptaszyński, J Wojcik… - Advances in Medical …, 2023 - Elsevier
Lung cancer is the second most frequently diagnosed cancer worldwide and a leading
cause of cancer-related deaths. Non-small cell lung carcinoma (NSCLC) represents 85% of …
cause of cancer-related deaths. Non-small cell lung carcinoma (NSCLC) represents 85% of …
A PI3K gene expression signature predicts for recurrence in early‐stage non–small cell lung cancer treated with stereotactic body radiation therapy
NT Sebastian, A Webb, K Shilo, R Robb… - Cancer, 2023 - Wiley Online Library
Introduction Increasingly, early‐stage non–small cell lung cancer (NSCLC) is treated with
stereotactic body radiation therapy (SBRT). Although treatment is generally effective, a small …
stereotactic body radiation therapy (SBRT). Although treatment is generally effective, a small …
Targeting protein synthesis pathways in MYC-amplified medulloblastoma
MYC is one of the most deregulated oncogenic transcription factors in human cancers. MYC
amplification/or overexpression is most common in Group 3 medulloblastoma and is …
amplification/or overexpression is most common in Group 3 medulloblastoma and is …
TNIK inhibition sensitizes TNIK-overexpressing lung squamous cell carcinoma to radiotherapy
Most patients with lung squamous cell carcinoma (LSCC) undergo chemotherapy,
radiotherapy, and adjuvant immunotherapy for locally advanced disease. The efficacy of …
radiotherapy, and adjuvant immunotherapy for locally advanced disease. The efficacy of …
Interplay of p62-mTORC1 and EGFR signaling promotes cisplatin resistance in oral cancer
HC Chang, CC Yang, LK Loi, CH Hung, CH Wu, YC Lin - Heliyon, 2024 - cell.com
Cisplatin resistance poses a major challenge in the treatment of oral squamous cell
carcinoma (OSCC). Deeper investigations into the mechanisms underlying this drug …
carcinoma (OSCC). Deeper investigations into the mechanisms underlying this drug …
MicroRNA‑203a‑3p suppresses endothelial cell proliferation and invasion, and promotes apoptosis in hemangioma by inactivating the VEGF‑mediated PI3K/AKT …
Z Hu, L Zhuo, Y Li, D Duan… - Experimental and …, 2022 - spandidos-publications.com
Our previous study demonstrated that microRNA-203a‑3p (miR‑203a‑3p) was involved in
the regulation of long non‑coding RNA MEG8‑mediated the progression of hemangioma …
the regulation of long non‑coding RNA MEG8‑mediated the progression of hemangioma …
[HTML][HTML] NSCLC: Contemporary Insights
M Broder, M Leapman - medpagetoday.com
Given high mortality risks, non-small cell lung cancer (NSCLC) requires timely treatment and
persistent management to improve patient outcomes. Surgery is a standard treatment …
persistent management to improve patient outcomes. Surgery is a standard treatment …